SHA:688578 Revenue

Shanghai Allist Pharmaceuticals had revenue of 1.36B CNY in the quarter ending September 30, 2025, with 42.03% growth. This brings the company's revenue in the last twelve months to 4.76B, up 48.49% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B with 76.29% growth.

Revenue (ttm)

4.76B

Revenue Growth

+48.49%

P/S Ratio

9.18

Revenue / Employee

3.36M

Employees

1,823

Market Cap

43.65B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.56B	1.54B	76.29%
Dec 31, 2023	2.02B	1.23B	155.14%
Dec 31, 2022	791.00M	260.91M	49.22%
Dec 31, 2021	530.09M	529.53M	94,409.97%
Dec 31, 2020	560.89K	-68.84K	-10.93%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pharmaron Beijing	13.54B
Chongqing Zhifei Biological Products	10.91B
Shanghai RAAS Blood Products	7.95B
Beijing Tiantan Biological Products	6.42B
Asymchem Laboratories (Tianjin)	6.29B
Haisco Pharmaceutical Group	4.27B
Hualan Biological Engineering	4.27B
Xiamen Amoytop Biotech	3.34B

Revenue Rankings